Abstract
In this edition of Blood, Chiesa et al have described excellent outcomes after allogeneic hematopoietic cell transplantation (allo-HCT) for 712 patients with chronic granulomatous disease (CGD). This study reports the largest published cohort to date by a significant margin.1
Cite
CITATION STYLE
APA
Morris, E. C. (2020). HCT for CGD? Yes, and the sooner the better. Blood, 136(10), 1121–1123. https://doi.org/10.1182/blood.2020007891
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free